Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHX
4301
DELISTED
PHX Minerals
PHX
| $60.1K | ﹤0.01% |
18,447
-33,257
| -64% | -$110K |
|
4302
Willis Lease Finance
WLFC
$1.68B
| $59.9K | ﹤0.01% |
2,595
+579
| +29% | +$11.2K |
|
4303
Grupo Cibest SA
CIB
$21.1B
| $59.6K | ﹤0.01% |
1,825
+335
| +22% | +$11.5K |
|
4304
Inhibrx
INBX
$1.17B
| $59.4K | ﹤0.01% |
+4,192
| New | +$65.5K |
|
4305
8x8 Inc
EGHT
$271M
| $59.3K | ﹤0.01% |
26,732
-5,731
| -18% | -$13.9K |
|
4306
Entravision Communication
EVC
$1.01B
| $59.3K | ﹤0.01% |
29,188
+17,768
| +156% | +$36.8K |
|
4307
Enanta Pharmaceuticals
ENTA
$367M
| $59.1K | ﹤0.01% |
4,558
+734
| +19% | +$9.91K |
|
4308
SES AI
SES
$196M
| $59.1K | ﹤0.01% |
47,255
+23,497
| +99% | +$31.9K |
|
|
AUTL
4309
Autolus Therapeutics
AUTL
$386M
| $59K | ﹤0.01% |
16,952
-65,633
| -79% | -$283K |
|
4310
Park-Ohio Holdings
PKOH
$564M
| $58.5K | ﹤0.01% |
2,261
+434
| +24% | +$11K |
|
4311
ClearPoint Neuro
CLPT
$436M
| $58.4K | ﹤0.01% |
10,839
+7,003
| +183% | +$40.5K |
|
4312
Solid Power
SLDP
$475M
| $58.3K | ﹤0.01% |
35,343
+5,857
| +20% | +$10.1K |
|
4313
Vuzix
VUZI
$187M
| $58.3K | ﹤0.01% |
43,197
+29,898
| +225% | +$41.2K |
|
|
GRTS
4314
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $58.3K | ﹤0.01% |
94,352
+77,412
| +457% | +$65.4K |
|
4315
BayCom
BCML
$335M
| $58.2K | ﹤0.01% |
2,862
-2,192
| -43% | -$43.6K |
|
|
ALTM
4316
PUT
DELISTED
Arcadium Lithium plc
ALTM
| $58.1K | ﹤0.01% |
17,280
-21,360
| -55% | -$89.2K |
|
4317
HighPeak Energy
HPK
$812M
| $58K | ﹤0.01% |
4,122
+1,516
| +58% | +$22.4K |
|
|
AILE
4318
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $57.9K | ﹤0.01% |
+6,377
| New | +$53.2K |
|
|
BRDG
4319
DELISTED
Bridge Investment Group
BRDG
| $57.7K | ﹤0.01% |
7,777
-69,516
| -90% | -$498K |
|
4320
Custom Truck One Source
CTOS
$2.35B
| $57.7K | ﹤0.01% |
13,258
+2,573
| +24% | +$12.5K |
|
4321
Climb Global Solutions
CLMB
$524M
| $57.5K | ﹤0.01% |
3,664
+844
| +30% | +$12.8K |
|
4322
EVgo
EVGO
$230M
| $57.1K | ﹤0.01% |
23,314
+4,015
| +21% | +$8.23K |
|
4323
ProFrac Holding
ACDC
$671M
| $56.9K | ﹤0.01% |
7,685
+2,746
| +56% | +$22.8K |
|
4324
Park Aerospace
PKE
$747M
| $56.9K | ﹤0.01% |
4,159
+655
| +19% | +$9.44K |
|
4325
Structure Therapeutics
GPCR
$3.4B
| $56.9K | ﹤0.01% |
1,448
+1,095
| +310% | +$45K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.